F3 Logic, LLC Blueprint Medicines Corp Transaction History

F3 Logic, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$72.9 - $101.41 $988,159 - $1.37 Million	-13,555 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$73.54 - $97.8 $367,700 - $489,000	-5,000 Reduced 26.95%	13,555 $1.28 Million
Q1 2019 May 06, 2019	BUY	$48.7 - $86.6 $903,628 - $1.61 Million	18,555 New	18,555 $1.49 Million

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of F3 Logic, LLC, based on Form 13F filings with the SEC.

Stay updated on F3 Logic, LLC with notifications on news.